This page is part of the FHIR Specification (v4.2.0: R5 Preview #1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions
Biomedical Research and Regulation Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile ClinicalUseIssue.
Generated Narrative with Details
id: example
type: contraindication
- | DiseaseSymptomProcedure | Comorbidity |
* | Hepatic disease associated with coagulopathy and clinically relevant bleeding risk (Details : {http://ema.europa.eu/example/contraindicationsasdisease-symptom-procedure code 'Coagulopathiesandbleedingdiatheses(exclthrombocytopenic)' = 'Coagulopathiesandbleedingdiatheses(exclthrombocytopenic)) | Hepaticdisease (Details : {http://ema.europa.eu/example/comorbidity code 'Hepaticdisease' = 'Hepaticdisease) |
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.